Monovalent Avian Influenza VLP (H7N9)

BIOLOGICAL2 trials

Sponsors

Novavax

Conditions

Avian InfluenzaInfluenza (Pandemic)

Phase 1

A(H7N9) VLP Antigen Dose Ranging Study With Adjuvant 1

CompletedNCT01897701

NovavaxAvian Influenza

Start: 2013-07-31End: 2014-08-31Updated: 2014-10-13

A(H7N9) VLP Antigen Dose-Ranging Study With Matrix-M1™ Adjuvant

CompletedNCT02078674

NovavaxInfluenza (Pandemic)

Start: 2014-03-31End: 2015-07-31Updated: 2016-09-23